Ligand Pharmaceuticals
LGND
₹9,222
Share price
-1.90%
Change (1 day)
51.29%
Change (1 year)
Operating Margin for Ligand Pharmaceuticals (LGND)
Operating Margin as of March 2025 (TTM): 1.50%
According to Ligand Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 1.50%. At the end of 2024 the company had an Operating Margin of 1.51%.
Operating Margin history for Ligand Pharmaceuticals from 2001 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | 1.51% | -96.89% |
| 2023 | 48.48% | 164.19% |
| 2022 | 18.35% | -38.61% |
| 2021 | 29.89% | 3684.35% |
| 2020 | 0.79% | -99.88% |
| 2019 | 662.31% | 860.82% |
| 2018 | 68.93% | 69.95% |
| 2017 | 40.56% | 455.27% |
| 2016 | 7.30% | -85.13% |
| 2015 | 49.13% | 180.53% |
| 2014 | 17.51% | -6.84% |
| 2013 | 18.80% | -252.66% |
| 2012 | -12.31% | 3.95% |
| 2011 | -11.85% | -81.9% |
| 2010 | -65.44% | 158.12% |
| 2009 | -25.35% | -92.9% |
| 2008 | -357.00% | -13.89% |
| 2007 | -414.58% | -78.13% |
| 2006 | -1,895.80% | 357.43% |
| 2005 | -414.45% | 1957.31% |
| 2004 | -20.15% | -82.69% |
| 2003 | -116.39% | 59.98% |
| 2002 | -72.75% | 140.04% |
| 2001 | -30.31% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | 13.78% | 818.67% | 🇺🇸 USA |
 | -109.76% | -7,417.33% | 🇺🇸 USA |
 | 10.93% | 628.67% | 🇬🇧 UK |
 | 31.06% | 1,970.67% | 🇺🇸 USA |
 | 12.60% | 740.00% | 🇺🇸 USA |
 | 28.15% | 1,776.67% | 🇺🇸 USA |
 | -17.34% | -1,256.00% | 🇺🇸 USA |
 | -4.61% | -407.33% | 🇺🇸 USA |
 | 18.78% | 1,152.00% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.